Botanical species · safety record

Aralia elata

The EFSA Compendium of Botanicals holds 1 constituent measurement and 3 adverse-effect records for Aralia elata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Aralia elata var. mandshurica (Rupr. & Maxim.) J.Wen

1Constituent measurements
3Safety records
3Cited sources
23Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 23 licensed products naming Aralia elata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Aged bark
  • Root

What the records describe

Constituents measured

  • Triterpene saponins1

Plant parts

  • Roots and other underground parts3
  • Roots and other underground parts used as staple food1

Preparations

  • Solvent extraction4

Effect types

  • Neurotoxicity2
  • Hepatotoxicity1

Target tissues

  • Neurologic: central nervous system2
  • Liver1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Triterpene saponinsRoots and other underground partsSolvent extractionUnspecifiedNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HepatotoxicityLiverRoots and other underground parts used as staple foodSolvent extractionPig (as animal)SubchronicResolve DOI
NeurotoxicityNeurologic: central nervous systemRoots and other underground partsSolvent extractionRat (as animal)Acute toxicityResolve DOI
NeurotoxicityNeurologic: central nervous systemRoots and other underground partsSolvent extractionRat (as animal)Acute toxicityResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. BURGOS, R., HANCKE, J., WIKMAN, G., CUBILLOS, V., CABALLERO, E., OYARZO, M., SANCHEZ, N. TOXICOLOGICAL ASSESSMENT OF ARALIA-MANDSHURICA (ARALIACEAE) ROOT EXTRACT AFTER SUBCHRONIC ADMINISTRATION IN RATS - A BIOCHEMICAL AND HISTOLOGICAL STUDY . Phytotherapy research, 1994, vol. 8, no. 1, p. 1-9. DOI
  2. Burgos, RA., Hancke, JL., Caceres, DD., Wilkman, G., Fuenzalida, H. Hepatotoxic effect of Aralia mandshurica dried root extract in pigs. Phytotherapy research, 1997, vol. 11, no. 1, p. 59-61. DOI
  3. Kochetkov, N. K., Khorlin, A. Ya., Vas'kovskii, V. E. Structures of aralosides A and B. Tetrahedron letters, 1962, p. 713-16.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue